Herpes simplex virus type 2 serological testing at a community court

Predictors of test acceptance and seropositivity among female defendants

A. M. Roth, B. Van Der Pol, J. Fortenberry, M. Reece, B. Dodge, D. Certo, Gregory Zimet

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Despite the high prevalence of herpes simplex virus type 2 (HSV-2), testing for asymptomatic infections is uncommon. One population for whom targeted interventions may be prioritized include individuals involved with the correctional system. Here we describe the acceptability of a novel HSV-2 screening program, implemented in a court setting, as a possible intervention for corrections-involved women. Female defendants completed an interviewer administered survey assessing factors associated with uptake/refusal of free point-of-care HSV-2 serologic testing and HSV-2 seropositivity. Participants included 143 women, 18-62 years old (mean 32.85) with diverse ethnicities. The majority (65.7%) accepted testing and 62.4% tested HSV-2 seropositive. Factors independently associated with test acceptance included higher perceived susceptibility to genital herpes infection and not receiving a preventative health screen. Women who were seropositive tended to be older, Black, report having previous STI, and be arrested on a prostitution charge. Findings suggest point-of-care testing in a court setting is acceptable to women and can be implemented to improve case finding of STI.

Original languageEnglish
Pages (from-to)169-174
Number of pages6
JournalInternational Journal of STD and AIDS
Volume24
Issue number3
DOIs
StatePublished - 2013

Fingerprint

Human Herpesvirus 2
Sexually Transmitted Diseases
Point-of-Care Systems
Sex Work
Herpes Genitalis
Asymptomatic Infections
Interviews
Health
Infection
Population

Keywords

  • Community court
  • Genital herpes
  • Herpes simplex virus type 2 (HSV-2)
  • Predictors
  • Seropositivity
  • Sexually transmitted infections
  • Testing

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Herpes simplex virus type 2 serological testing at a community court : Predictors of test acceptance and seropositivity among female defendants. / Roth, A. M.; Van Der Pol, B.; Fortenberry, J.; Reece, M.; Dodge, B.; Certo, D.; Zimet, Gregory.

In: International Journal of STD and AIDS, Vol. 24, No. 3, 2013, p. 169-174.

Research output: Contribution to journalArticle

@article{ec5a07d185d449dab51f349dc32e7347,
title = "Herpes simplex virus type 2 serological testing at a community court: Predictors of test acceptance and seropositivity among female defendants",
abstract = "Despite the high prevalence of herpes simplex virus type 2 (HSV-2), testing for asymptomatic infections is uncommon. One population for whom targeted interventions may be prioritized include individuals involved with the correctional system. Here we describe the acceptability of a novel HSV-2 screening program, implemented in a court setting, as a possible intervention for corrections-involved women. Female defendants completed an interviewer administered survey assessing factors associated with uptake/refusal of free point-of-care HSV-2 serologic testing and HSV-2 seropositivity. Participants included 143 women, 18-62 years old (mean 32.85) with diverse ethnicities. The majority (65.7{\%}) accepted testing and 62.4{\%} tested HSV-2 seropositive. Factors independently associated with test acceptance included higher perceived susceptibility to genital herpes infection and not receiving a preventative health screen. Women who were seropositive tended to be older, Black, report having previous STI, and be arrested on a prostitution charge. Findings suggest point-of-care testing in a court setting is acceptable to women and can be implemented to improve case finding of STI.",
keywords = "Community court, Genital herpes, Herpes simplex virus type 2 (HSV-2), Predictors, Seropositivity, Sexually transmitted infections, Testing",
author = "Roth, {A. M.} and {Van Der Pol}, B. and J. Fortenberry and M. Reece and B. Dodge and D. Certo and Gregory Zimet",
year = "2013",
doi = "10.1177/0956462412472442",
language = "English",
volume = "24",
pages = "169--174",
journal = "International Journal of STD and AIDS",
issn = "0956-4624",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Herpes simplex virus type 2 serological testing at a community court

T2 - Predictors of test acceptance and seropositivity among female defendants

AU - Roth, A. M.

AU - Van Der Pol, B.

AU - Fortenberry, J.

AU - Reece, M.

AU - Dodge, B.

AU - Certo, D.

AU - Zimet, Gregory

PY - 2013

Y1 - 2013

N2 - Despite the high prevalence of herpes simplex virus type 2 (HSV-2), testing for asymptomatic infections is uncommon. One population for whom targeted interventions may be prioritized include individuals involved with the correctional system. Here we describe the acceptability of a novel HSV-2 screening program, implemented in a court setting, as a possible intervention for corrections-involved women. Female defendants completed an interviewer administered survey assessing factors associated with uptake/refusal of free point-of-care HSV-2 serologic testing and HSV-2 seropositivity. Participants included 143 women, 18-62 years old (mean 32.85) with diverse ethnicities. The majority (65.7%) accepted testing and 62.4% tested HSV-2 seropositive. Factors independently associated with test acceptance included higher perceived susceptibility to genital herpes infection and not receiving a preventative health screen. Women who were seropositive tended to be older, Black, report having previous STI, and be arrested on a prostitution charge. Findings suggest point-of-care testing in a court setting is acceptable to women and can be implemented to improve case finding of STI.

AB - Despite the high prevalence of herpes simplex virus type 2 (HSV-2), testing for asymptomatic infections is uncommon. One population for whom targeted interventions may be prioritized include individuals involved with the correctional system. Here we describe the acceptability of a novel HSV-2 screening program, implemented in a court setting, as a possible intervention for corrections-involved women. Female defendants completed an interviewer administered survey assessing factors associated with uptake/refusal of free point-of-care HSV-2 serologic testing and HSV-2 seropositivity. Participants included 143 women, 18-62 years old (mean 32.85) with diverse ethnicities. The majority (65.7%) accepted testing and 62.4% tested HSV-2 seropositive. Factors independently associated with test acceptance included higher perceived susceptibility to genital herpes infection and not receiving a preventative health screen. Women who were seropositive tended to be older, Black, report having previous STI, and be arrested on a prostitution charge. Findings suggest point-of-care testing in a court setting is acceptable to women and can be implemented to improve case finding of STI.

KW - Community court

KW - Genital herpes

KW - Herpes simplex virus type 2 (HSV-2)

KW - Predictors

KW - Seropositivity

KW - Sexually transmitted infections

KW - Testing

UR - http://www.scopus.com/inward/record.url?scp=84890161185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890161185&partnerID=8YFLogxK

U2 - 10.1177/0956462412472442

DO - 10.1177/0956462412472442

M3 - Article

VL - 24

SP - 169

EP - 174

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

SN - 0956-4624

IS - 3

ER -